Health ❯ Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Drug Safety Clinical Trials Weight Loss Weight Loss Drugs Drug Regulation Cancer Treatment Medications

Once-Daily GLP-1 Pill Delivers Nearly 10% Weight Loss in Phase 3 Trial of Adults With Diabetes

The oral small molecule orforglipron offers a refrigeration-free option that could widen access to incretin therapy if regulators approve it.

Missouri, Kansas and Idaho Sue to Block FDA Approval of New Generic Mifepristone

New Zealand Pauses New Puberty Blocker Prescriptions for Gender Dysphoria

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

FDA OKs RVO Use and Monthly Dosing for Regeneron’s Eylea HD

FDA Approves Koselugo for Adults With NF1-Related Plexiform Neurofibromas

Merck to Buy Cidara for $9.2 Billion to Secure Long‑Acting Flu Preventive

Stories older than 24h

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

First Lenacapavir Shipments Reach Zambia and Eswatini as U.S. Excludes South Africa From Donated Doses

FDA Approves Epkinly Monotherapy and Triplet Regimen for Relapsed Follicular Lymphoma

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

Olema Soars on Roche SERD Win, Then Slips on Planned Stock Offering

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

MoonLake Investors Get Deadline Reminder as Securities Suits Mount Over Sonelokimab Trial

Brain Implants Show Mounjaro Temporarily Quiets Food-Craving Brain Signal

Roche Says Breast Cancer Pill Cuts Recurrence in Phase 3 Adjuvant Trial

Nuvalent Reports 31% ORR in Pretreated, 86% in Untreated ALK+ NSCLC With Neladalkib

Yale Study Finds Only 24% of Medicines Tested Reach Trial-Host Countries Within Five Years

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer